UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1805) 1805
Book Chapter (47) 47
Newspaper Article (6) 6
Dissertation (2) 2
Publication (2) 2
Book Review (1) 1
Journal / eJournal (1) 1
Newsletter (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1461) 1461
science & technology (1296) 1296
life sciences & biomedicine (1263) 1263
administration, oral (1100) 1100
male (943) 943
female (939) 939
oncology (744) 744
middle aged (714) 714
aged (667) 667
adult (602) 602
etoposide - administration & dosage (596) 596
antineoplastic combined chemotherapy protocols - therapeutic use (402) 402
chemotherapy (398) 398
cancer (345) 345
drug administration schedule (310) 310
pharmacology & pharmacy (305) 305
treatment outcome (290) 290
etoposide (243) 243
animals (224) 224
lung neoplasms - drug therapy (218) 218
aged, 80 and over (213) 213
etoposide - adverse effects (212) 212
antineoplastic combined chemotherapy protocols - adverse effects (195) 195
dentistry (187) 187
medicine & public health (187) 187
adolescent (185) 185
etoposide - therapeutic use (183) 183
dentistry, oral surgery & medicine (175) 175
antineoplastic agents, phytogenic - administration & dosage (171) 171
care and treatment (170) 170
neoplasms - drug therapy (155) 155
antineoplastic combined chemotherapy protocols - administration & dosage (147) 147
child (144) 144
antineoplastic agents - administration & dosage (143) 143
infusions, intravenous (143) 143
dose-response relationship, drug (132) 132
cisplatin - administration & dosage (129) 129
hematology (127) 127
biological availability (125) 125
analysis (124) 124
research (115) 115
health aspects (114) 114
surgery (113) 113
survival analysis (113) 113
carcinoma, small cell - drug therapy (112) 112
pharmacology/toxicology (112) 112
survival rate (112) 112
pharmacokinetics (110) 110
antineoplastic agents - adverse effects (109) 109
antineoplastic agents - therapeutic use (106) 106
retrospective studies (106) 106
tumors (104) 104
child, preschool (103) 103
follow-up studies (103) 103
remission induction (102) 102
abridged index medicus (101) 101
drug therapy (101) 101
injections, intravenous (100) 100
oral etoposide (95) 95
apoptosis (93) 93
cyclophosphamide - administration & dosage (93) 93
neoplasm staging (90) 90
carcinoma, non-small-cell lung - drug therapy (89) 89
prognosis (89) 89
neoplasm recurrence, local - drug therapy (88) 88
disease-free survival (85) 85
antineoplastic agents (81) 81
cancer therapies (81) 81
rats (81) 81
etoposide - pharmacokinetics (80) 80
time factors (80) 80
metastasis (79) 79
cisplatin (77) 77
oral administration (75) 75
patients (75) 75
dosage and administration (74) 74
pediatrics (74) 74
young adult (74) 74
combined modality therapy (73) 73
lung neoplasms - pathology (73) 73
oral mucositis (73) 73
risk factors (73) 73
antimitotic agents (72) 72
antineoplastic agents, phytogenic - adverse effects (72) 72
transplantation (72) 72
mice (71) 71
prospective studies (71) 71
bioavailability (70) 70
antineoplastic agents, phytogenic - therapeutic use (69) 69
adenocarcinoma - drug therapy (68) 68
clinical trials (68) 68
medicine (68) 68
area under curve (66) 66
drug interactions (66) 66
cell line, tumor (65) 65
pathology (64) 64
ovarian neoplasms - drug therapy (62) 62
quality of life (61) 61
stem cells (59) 59
toxicity (59) 59
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1774) 1774
Japanese (129) 129
German (10) 10
French (9) 9
Portuguese (4) 4
Hungarian (3) 3
Polish (2) 2
Chinese (1) 1
Russian (1) 1
Serbian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
LONG TERM ORAL ETOPOSIDE AS SECOND-LINE THERAPY IN RECURRENT EPITHELIAL CARCINOMA OF THE OVARY, 12/2005
Background: The activity and toxicity of etoposide in women with recurrent ovarian cancer was evaluated in a case series of women with recurrent ovarian cancer who had measurable disease. Methods... 
Oral etoposide, recurrent epithelial ovarian cancer, second-line chemotherapy
Journal
Experimental and therapeutic medicine, ISSN 1792-0981, 09/2010, Volume 1, Issue 5, pp. 739 - 746
Journal Article
Journal Article